mlsanityData to 14 Oct 2026

Fluorescence molecular optomic signatures improve identification of tumors in head and neck specimens

arXiv 2208.13314 ↗First posted 29 Aug 2022cs.LG cs.CVcited by 0

Not on the map. Why?

Abstract (arXiv)

In this study, a radiomics approach was extended to optical fluorescence molecular imaging data for tissue classification, termed 'optomics'. Fluorescence molecular imaging is emerging for precise surgical guidance during head and neck squamous cell carcinoma (HNSCC) resection. However, the tumor-to-normal tissue contrast is confounded by intrinsic physiological limitations of heterogeneous expression of the target molecule, epidermal growth factor receptor (EGFR). Optomics seek to improve tumor identification by probing textural pattern differences in EGFR expression conveyed by fluorescence. A total of 1,472 standardized optomic features were extracted from fluorescence image samples. A supervised machine learning pipeline involving a support vector machine classifier was trained with 25 top-ranked features selected by minimum redundancy maximum relevance criterion. Model predictive performance was compared to fluorescence intensity thresholding method by classifying testing set image patches of resected tissue with histologically confirmed malignancy status. The optomics approach provided consistent improvement in prediction accuracy on all test set samples, irrespective of dose, compared to fluorescence intensity thresholding method (mean accuracies of 89% vs. 81%; P = 0.0072). The improved performance demonstrates that extending the radiomics approach to fluorescence molecular imaging data offers a promising image analysis technique for cancer detection in fluorescence-guided surgery.

Key facts. No citing papers in the map yet (data through 14 Oct 2026). Builds on 1 of its 72 references that are in the map. First posted on arXiv 29 Aug 2022.

Builds on

1 of 72 references.

References · 1

  1. 2016Image biomarker standardisation initiativecited by 63

Built on by

Not cited yet.